This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Akito Sakai: Innovator in Hepatitis C Research
Introduction
Akito Sakai is a notable inventor based in Ishikawa, Japan. He has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). His work has implications for diagnostics and antiviral drug development.
Latest Patents
Sakai holds a patent for the cloned genome of the infectious hepatitis C virus strain HC-TN. This patent includes nucleic acid sequences that encode proteins and polypeptides of the HCV strain HC-TN, genotype 1a. The embodiments described in the patent also contemplate the use of these compositions in diagnostics for HCV and in the development of screening assays for identifying antiviral agents.
Career Highlights
He is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been pivotal in advancing the understanding of hepatitis C and its treatment options.
Collaborations
Sakai has collaborated with prominent researchers in the field, including Jens Bukh and Robert H. Purcell. These collaborations have furthered the research and development of effective strategies against hepatitis C.
Conclusion
Akito Sakai's contributions to hepatitis C research through his innovative patent highlight the importance of scientific advancements in combating viral infections. His work continues to influence the field and offers hope for improved diagnostics and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile